99 related articles for article (PubMed ID: 9375821)
21. MDR1 causes resistance to the antitumour drug miltefosine.
Rybczynska M; Liu R; Lu P; Sharom FJ; Steinfels E; Pietro AD; Spitaler M; Grunicke H; Hofmann J
Br J Cancer; 2001 May; 84(10):1405-11. PubMed ID: 11355955
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.
Raghu G; Park SW; Roninson IB; Mechetner EB
Exp Hematol; 1996 Aug; 24(10):1258-64. PubMed ID: 8765502
[TBL] [Abstract][Full Text] [Related]
23. Nephron specific regulation of chloride channel CLC-K2 mRNA in the rat.
Vitzthum H; Castrop H; Meier-Meitinger M; Riegger GA; Kurtz A; Krämer BK; Wolf K
Kidney Int; 2002 Feb; 61(2):547-54. PubMed ID: 11849395
[TBL] [Abstract][Full Text] [Related]
24. Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity.
Arias A; Rigalli JP; Villanueva SS; Ruiz ML; Luquita MG; Perdomo VG; Vore M; Catania VA; Mottino AD
Toxicology; 2014 Jun; 320():46-55. PubMed ID: 24685904
[TBL] [Abstract][Full Text] [Related]
25. Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines.
Herzog CE; Trepel JB; Mickley LA; Bates SE; Fojo AT
J Natl Cancer Inst; 1992 May; 84(9):711-6. PubMed ID: 1349044
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical detection of the p170 multidrug resistance (MDR) and the p53 tumor suppressor gene proteins in human breast cancer cells: clinical and therapeutical significance.
Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE
Anticancer Res; 1997; 17(2B):1311-8. PubMed ID: 9137491
[TBL] [Abstract][Full Text] [Related]
27. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
[TBL] [Abstract][Full Text] [Related]
28. Influence of different chemicals on MDR-1 P-glycoprotein expression and activity in the HK-2 proximal tubular cell line.
Romiti N; Tramonti G; Chieli E
Toxicol Appl Pharmacol; 2002 Sep; 183(2):83-91. PubMed ID: 12387747
[TBL] [Abstract][Full Text] [Related]
29. Evidence of Oatp and Mdr1 in cryopreserved rat hepatocytes.
Jørgensen L; Van Beek J; Lund S; Schousboe A; Badolo L
Eur J Pharm Sci; 2007 Feb; 30(2):181-9. PubMed ID: 17174077
[TBL] [Abstract][Full Text] [Related]
30. Expression of mdr1/P-glycoprotein and p110 in neuroblastoma.
Ramani P; Dewchand H
J Pathol; 1995 Jan; 175(1):13-22. PubMed ID: 7891222
[TBL] [Abstract][Full Text] [Related]
31. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
[TBL] [Abstract][Full Text] [Related]
32. Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells.
Nadali F; Pourfathollah AA; Alimoghaddam K; Nikougoftar M; Rostami S; Dizaji A; Azizi E; Zomorodipour A; Ghavamzadeh A
Hematology; 2007 Oct; 12(5):393-401. PubMed ID: 17852455
[TBL] [Abstract][Full Text] [Related]
33. The co-localization of stanniocalcin protein, mRNA and kidney cell markers in the rat kidney.
Wong CK; Ho MA; Wagner GF
J Endocrinol; 1998 Aug; 158(2):183-9. PubMed ID: 9771461
[TBL] [Abstract][Full Text] [Related]
34. Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.
Hafkemeyer P; Dey S; Ambudkar SV; Hrycyna CA; Pastan I; Gottesman MM
Biochemistry; 1998 Nov; 37(46):16400-9. PubMed ID: 9819232
[TBL] [Abstract][Full Text] [Related]
35. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
[TBL] [Abstract][Full Text] [Related]
36. P-glycoprotein in autoimmune rheumatic diseases.
García-Carrasco M; Mendoza-Pinto C; Macias Díaz S; Vera-Recabarren M; Vázquez de Lara L; Méndez Martínez S; Soto-Santillán P; González-Ramírez R; Ruiz-Arguelles A
Autoimmun Rev; 2015 Jul; 14(7):594-600. PubMed ID: 25712147
[TBL] [Abstract][Full Text] [Related]
37. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.
Luker GD; Rao VV; Crankshaw CL; Dahlheimer J; Piwnica-Worms D
Biochemistry; 1997 Nov; 36(46):14218-27. PubMed ID: 9369495
[TBL] [Abstract][Full Text] [Related]
38. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel.
Takara K; Obata Y; Yoshikawa E; Kitada N; Sakaeda T; Ohnishi N; Yokoyama T
Cancer Chemother Pharmacol; 2006 Dec; 58(6):785-93. PubMed ID: 16534613
[TBL] [Abstract][Full Text] [Related]
39. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
[TBL] [Abstract][Full Text] [Related]
40. Expression of the multidrug-resistance 1 (MDR1) gene and prognosis in human pancreatic cancer.
Lu Z; Kleeff J; Shrikhande S; Zimmermann T; Korc M; Friess H; Büchler MW
Pancreas; 2000 Oct; 21(3):240-7. PubMed ID: 11039467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
